Glen Tullman

Glen Tullman is the Chief Executive Officer of Transcarent, the first comprehensive, consumer-directed health and care platform for employees of self-insured employers and their families. He is also one of two Founding Partners at 7wireVentures, one of the highest returning venture capital funds in Illinois. He is the author of On Our Terms: Empowering the New Health Consumer, in which he proposes new solutions to address the chronic-condition epidemic facing our country.

He is the former Executive Chairman, Chief Executive Officer, and Founder of Livongo Health, the first at-scale consumer digital health company to truly empower people with chronic conditions to live better and healthier lives using data science. Glen previously ran two other public companies that changed the way health care is delivered. During his time as Chief Executive Officer of Allscripts, the Company was the leading provider of electronic prescribing, practice management, and electronic health records. Glen led Allscripts IPO and Secondary offerings.

Glen is dedicated to finding a cure for diabetes and other chronic conditions—and to keeping people healthy until cures are found. A strong proponent of philanthropy, he was honored in 2019 with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system. He also serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation and has served as a Board Member of the American Diabetes Association. 

He received his undergraduate degree in 1981 in economics and psychology from Bucknell University and came in 1982 to st Antony’s to study social anthropology on a Rotary International Fellowship.